About 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide
4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide (PubChem CID 25263910) has the molecular formula C33H36N6O5
and a molecular weight of 596.69 g/mol. Its IUPAC name is 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide.
Molecular Properties
| Compound Name | 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide |
| PubChem CID | 25263910 |
| Molecular Formula | C33H36N6O5 |
| Molecular Weight | 596.69 g/mol |
| Exact Mass | 596.27 |
| IUPAC Name | 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide |
| SMILES | Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2O)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)n1 |
| InChI | InChI=1S/C33H36N6O5/c1-20-23(7-6-8-25(20)36-30(41)24-11-10-22(17-28(24)40)33(2,3)4)26-18-27(32(43)38(5)37-26)35-29-12-9-21(19-34-29)31(42)39-13-15-44-16-14-39/h6-12,17-19,40H,13-16H2,1-5H3,(H,34,35)(H,36,41) |
| InChIKey | PJLZFUACOJYOEB-UHFFFAOYSA-N |
| XLogP | 4.62 |
| TPSA | 138.68 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 596.69 |
| LogP ≤ 5 | 4.62 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Analyze 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide?
The IUPAC name of 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide (CID 25263910) is 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide.
What is the SMILES notation for 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide?
The canonical SMILES for 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide is Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2O)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)n1.
What is the InChIKey of 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide?
The InChIKey is PJLZFUACOJYOEB-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H36N6O5/c1-20-23(7-6-8-25(20)36-30(41)24-11-10-22(17-28(24)40)33(2,3)4)26-18-27(32(43)38(5)37-26)35-29-12-9-21(19-34-29)31(42)39-13-15-44-16-14-39/h6-12,17-19,40H,13-16H2,1-5H3,(H,34,35)(H,36,41).
What are the key properties of 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide?
4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide has a molecular weight of 596.69 g/mol, XLogP of 4.62, 6 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 4-tert-butyl-2-hydroxy-N-[2-methyl-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxopyridazin-3-yl]phenyl]benzamide is sourced from PubChem (CID 25263910), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).